π¬
|
A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis
D. Shirley,
Laura Farr,
Koji Watanabe,
S. Moonah
|
8 |
2018 |
8 π¬
|
π¦
|
Environmental Enteropathy: Elusive but Significant Subclinical Abnormalities in Developing Countries
Koji Watanabe,
W. Petri
|
6 |
2016 |
6 π¦
|
π
|
Impact of Small Body Weight on Tenofovir-Associated Renal Dysfunction in HIV-Infected Patients: A Retrospective Cohort Study of Japanese Patients
14 auth.
T. Nishijima,
H. Komatsu,
H. Gatanaga,
T. Aoki,
Koji Watanabe,
E. Kinai,
H. Honda,
J. Tanuma,
H. Yazaki,
K. Tsukada,
...
M. Honda,
K. Teruya,
Y. Kikuchi,
S. Oka
|
6 |
2011 |
6 π
|
π
|
Role of the Gut Microbiota of Children in Diarrhea Due to the Protozoan Parasite Entamoeba histolytica
15 auth.
C. Gilchrist,
Sarah E. Petri,
Brittany N Schneider,
Daniel Reichman,
Nona M. Jiang,
Sharmin Begum,
Koji Watanabe,
Caroline S. Jansen,
K. Pamela Elliott,
S. Burgess,
...
Jennie Z. Ma,
Masud Alam,
M. Kabir,
R. Haque,
William A. Petri
|
6 |
2015 |
6 π
|
π
|
High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy.
9 auth.
Yohei Hamada,
T. Nishijima,
Koji Watanabe,
H. Komatsu,
K. Tsukada,
K. Teruya,
...
H. Gatanaga,
Y. Kikuchi,
S. Oka
|
6 |
2012 |
6 π
|
π
|
Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up
15 auth.
T. Nishijima,
Y. Kawasaki,
Noriko Tanaka,
Daisuke Mizushima,
T. Aoki,
Koji Watanabe,
E. Kinai,
H. Honda,
H. Yazaki,
J. Tanuma,
...
K. Tsukada,
K. Teruya,
Y. Kikuchi,
H. Gatanaga,
S. Oka
|
6 |
2014 |
6 π
|
π¦
|
Microbiome-mediated neutrophil recruitment via CXCR2 and protection from amebic colitis
17 auth.
Koji Watanabe,
C. Gilchrist,
M. Uddin,
S. Burgess,
Mayuresh M. Abhyankar,
S. Moonah,
Zannatun Noor,
Jeffrey R. Donowitz,
Brittany N Schneider,
Tuhinur Arju,
...
Emtiaz Ahmed,
M. Kabir,
Masud Alam,
R. Haque,
P. Pramoonjago,
B. Mehrad,
W. Petri
|
6 |
2017 |
6 π¦
|
π
|
Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients
23 auth.
Yuta Takahashi,
N. Nagata,
T. Shimbo,
T. Nishijima,
Koji Watanabe,
Tomonori Aoki,
K. Sekine,
H. Okubo,
Kazuhiro Watanabe,
T. Sakurai,
...
C. Yokoi,
M. Kobayakawa,
H. Yazaki,
K. Teruya,
H. Gatanaga,
Y. Kikuchi,
S. Mine,
T. Igari,
Y. Takahashi,
A. Mimori,
S. Oka,
J. Akiyama,
N. Uemura
|
6 |
2015 |
6 π
|
π¦
|
Amebiasis in HIV-1-Infected Japanese Men: Clinical Features and Response to Therapy
Koji Watanabe,
H. Gatanaga,
A. Cadiz,
J. Tanuma,
T. Nozaki,
S. Oka
|
6 |
2011 |
6 π¦
|
π
|
Renal Function Declines More in Tenofovir- than Abacavir-Based Antiretroviral Therapy in Low-Body Weight Treatment-NaΓ―ve Patients with HIV Infection
15 auth.
T. Nishijima,
H. Gatanaga,
H. Komatsu,
K. Tsukada,
T. Shimbo,
T. Aoki,
Koji Watanabe,
E. Kinai,
H. Honda,
J. Tanuma,
...
H. Yazaki,
M. Honda,
K. Teruya,
Y. Kikuchi,
S. Oka
|
5 |
2012 |
5 π
|